Full analysis of bedaquiline medical insurance reimbursement

Bedaquiline, a new anti-tuberculosis drug developed specifically for patients with multidrug-resistant tuberculosis (MDR-TB), has attracted widespread attention for its excellent efficacy since its introduction. For many patients who have been battling the disease for a long time, the emergence of bedaquiline is undoubtedly a ray of hope. In China, an exciting news came: bedaquiline has been officially included in the national medical insurance directory, which means that the financial burden of patients will be greatly reduced, and the road to treatment will become smoother.

The price of bedaquiline was once prohibitive for patients. Taking the common specifications of 100mg*24 tablets in China as an example, the price of a box is as high as 6,000 to 7,000 yuan. However, as it is included in medical insurance, the actual costs paid by patients will be significantly reduced. Specific reimbursement ratios and reimbursement policies vary by region. Patients can learn more about local medical insurance policies and purchase drugs at designated hospitals or pharmacies.

It is worth mentioning that although the domestic price of bedaquiline is high, there is still a certain gap compared with foreign prices. For example, the Russian version of the original drug 100 mg 188 tablets costs about more than 10,000 yuan, while the generic drug of the same specification produced in India is more affordable and only costs more than 2,000 yuan. Although generic drugs have a price advantage, their drug ingredients and efficacy are basically the same as those of brand-name drugs, providing patients with more choices.

For patients who are eligible for medical insurance reimbursement, the inclusion of bedaquiline in medical insurance is undoubtedly a good news. After reimbursement, patients only need to pay the out-of-pocket portion, and the financial pressure is significantly relieved. However, the specific reimbursement ratio and reimbursement process vary from region to region. Patients need to go to a designated medical insurance hospital to diagnose and issue a prescription, and then reimburse according to the regulations of the local medical insurance agency.